MSB 1.49% $1.02 mesoblast limited

Alzheimer drug approved, page-19

  1. 6,445 Posts.
    lightbulb Created with Sketch. 2625
    Had a quick read of Bauer's yet to be peer reviewed paper, I get a sense that the new additional data being generated by mesoblast will be in line with what is being suggested by Bauer's experiments. Not sure why priming is being treated as some kind of new discovery given Mesoblast have been doing for years in their manufacturing processes. They have also been refining their donor selection criteria over many years (I suspect in a proprietary, commercially sensitive way, given their years of R&D in this area) and likely an issue with Bauer's off the shelf donors from their suppliers. Anyway, it gives me a better sense of FDA's thinking.

    https://www.biorxiv.org/content/10.1101/2021.02.23.432501v1.full

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.02
Change
0.015(1.49%)
Mkt cap ! $1.164B
Open High Low Value Volume
$1.00 $1.04 94.0¢ $11.76M 11.90M

Buyers (Bids)

No. Vol. Price($)
6 206912 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 37637 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.